Highlights

Trader Hub

Author: traderhub8   |   Latest post: Fri, 20 May 2022, 9:29 AM

 

Venture Corporation Limited - Disrupted Quarter

Author:   |    Publish date:


  • Results were below forecast. 3Q21 PATMI declined 4% YoY to S$77mn. YTD21 Revenue and PATMI were 66% and 63% respectively.
  • Fulfilment of customer orders disrupted by global components shortages and the Extended Movement Control Order (or factory closures) in Malaysia.
  • We are lowering our FY21e revenue and PATMI by 6% and 10% respectively. Recovery this quarter has been stalled due to production disruptions. The company mentioned that demand is healthy and broad-based demand. In addition, the workforce in Malaysia is almost fully vaccinated, which should allow manufacturing activities to resume as normal. We expect some spill-over of orders into 4Q21. We maintain our NEUTRAL recommendation. Our target price is rolled over to 16x PE FY22e, its 5-year average. Re-opening and removal of lockdown should ease pressure on the supply chain in FY22e. The share price is currently supported by dividend yields of 4.5%, 11% ROEs and S$853mn net cash.

The Positive

+ Healthy balance sheet and margins. Net margins improved marginally to 10%. We assume the high-value low mix projects have been sustaining margins despite the weaker revenue and loss of operating leverage. Net cash was S$853mn at 3Q21. There was a spike in inventory by S$154mn YoY to S$908mn. We believe there is buffer inventory to cope with the unpredictability in component supply.

 

The Negative

– Another weak quarter in revenue. Pre-pandemic, the quarterly run-rate in revenue was around S$900mn. This has dropped to S$700m this year. Venture has struggled to keep revenues to pre-pandemic levels these past two years despite the global resurgence in electronics demand. The pivot to life science and consequent long timeline to ramp up is a factor, in our opinion. We expect revenue to rebound in 4Q21e to S$916mn, an 11% YoY rise.

 

Outlook

Venture commented that new product introductions are expected to flow to mass production over the next 12 months.

 

Maintain NEUTRAL with unchanged TP of S$19.20

Our FY21e and FY22e PATMI is lowered by 10% and 11% respectively

Source: Phillip Capital Research - 5 Nov 2021

Share this
Labels: Venture

Related Stocks

Chart Stock Name Last Change Volume 
Venture 17.21 -0.15 (0.86%) 541,300 

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

135  258  191  594 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 Sembcorp Marine 0.106+0.003 
 YZJ Fin Hldg 0.475+0.04 
 Jiutian Chemical 0.11-0.001 
 AA 0.014-0.003 
 HSI 21400MBeC.. 0.058-0.017 
 Parkson Retail 0.048+0.003 
 Dyna-Mac 0.151+0.004 
 HSI 18200MBeP.. 0.061+0.009 
 Tritech 0.037+0.002 
 Genting Sing 0.78-0.01 
PARTNERS & BROKERS